Yehuda Reznick - Jun 5, 2025 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Yehuda Reznick
Stock symbol
ORMP
Transactions as of
Jun 5, 2025
Transactions value $
$0
Form type
4
Date filed
6/9/2025, 04:08 PM
Previous filing
Jun 10, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reznick Yehuda Director 1185 AVENUE OF THE AMERICAS,, THIRD FLOOR, NEW YORK /s/ Yehuda Reznick 2025-06-09 0002015556

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +30K +98.17% 60.6K Jun 5, 2025 Direct F1
transaction ORMP Common Stock Award +8.37K +13.82% 68.9K Jun 5, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2 Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.